GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma

GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma

ObjectivePancreatic ductal adenocarcinoma (PDAC) is a highly malignant neoplasm with rising incidence worldwide. Gremlin 1 (GREM1), a regulator of bone morphogenetic protein (BMP) signaling, fine-tunes extensive biological processes, including organ morphology, cellular metabolism, and multiple path...

Full description

Bibliographic Details
Main Authors: Sen Yang, Yalu Zhang, Yuze Hua, Ming Cui, Mengyi Wang, Junyi Gao, Qiaofei Liu, Quan Liao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
gremlin 1 (GREM1)
pancreatic adenocarcinoma (PDAC)
tumor microenvironment
diagnosis
marker
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.968610/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.968610/full

Similar Items